For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, SELLAS Life Sciences Group Inc’s stock clocked out at $1.63, up 5.84% from its previous closing price of $1.54. In other words, the price has increased by $5.84 from its previous closing price. On the day, 2.02 million shares were traded. SLS stock price reached its highest trading level at $1.72 during the session, while it also had its lowest trading level at $1.46.
Ratios:
To gain a deeper understanding of SLS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.23 and its Current Ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.
On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLS now has a Market Capitalization of 91716352 and an Enterprise Value of 85028208.
Stock Price History:
Over the past 52 weeks, SLS has reached a high of $1.91, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 43.06%, while the 200-Day Moving Average is calculated to be 38.24%.
Shares Statistics:
It appears that SLS traded 1.42M shares on average per day over the past three months and 1214970 shares per day over the past ten days. A total of 56.27M shares are outstanding, with a floating share count of 55.88M. Insiders hold about 0.69% of the company’s shares, while institutions hold 9.93% stake in the company. Shares short for SLS as of 1711584000 were 5272228 with a Short Ratio of 3.70, compared to 1709164800 on 4513118. Therefore, it implies a Short% of Shares Outstanding of 5272228 and a Short% of Float of 9.379999999999999.
Earnings Estimates
The firm’s stock currently is rated by 3.0 analysts. On average, analysts expect EPS of -$0.21 for the current quarter, with a high estimate of -$0.16 and a low estimate of -$0.25, while EPS last year was -$0.47. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.16 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.6 and -$1.15 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.85, with 4.0 analysts recommending between -$0.5 and -$1.28.
